Hans‐Peter Sinn
Impact in
- Cancer Research top 0.2%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 0.2%
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
Papers in
- Cancer Research 133
- Breast Cancer Treatment Studies 106
- Cancer Genomics and Diagnostics 26
- Oncology 109
- Cancer Cells and Metastasis 31
- HER2/EGFR in Cancer Research 29
- Cancer Immunotherapy and Biomarkers 18
- Co-authors
- Andreas Schneeweiß (66 shared papers)Hans Heinrich Kreipe (5 shared papers)Sebastian Aulmann (30 shared papers)H. Junkermann (11 shared papers)Frederik Marmé (21 shared papers)Christof Sohn (36 shared papers)Florian Schütz (25 shared papers)Michael Golatta (21 shared papers)
- Journals
- Breast Care (21 papers)Breast Cancer Research and Treatment (13 papers)International Journal of Cancer (13 papers)Annals of Oncology (10 papers)Modern Pathology (8 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Hans‐Peter Sinn
317 papers receiving 15.4k citations
Hans‐Peter Sinn's Hit Papers
Peers
Comparison fields: 5 of 169
- Cancer Research 5.0k
- Oncology 5.9k
- Pathology and Forensic Medicine 1.3k
- Immunology 1.6k
- Radiology, Nuclear Medicine and Imaging 1.5k
Countries citing papers authored by Hans‐Peter Sinn
This map shows the geographic impact of Hans‐Peter Sinn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans‐Peter Sinn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans‐Peter Sinn more than expected).
Fields of papers citing papers by Hans‐Peter Sinn
This network shows the impact of papers produced by Hans‐Peter Sinn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans‐Peter Sinn. The network helps show where Hans‐Peter Sinn may publish in the future.
Co-authors
The 25 scholars most cited alongside Hans‐Peter Sinn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 333 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy Hit paper breakdown → | 2017 | 1666 |
| 2 | Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay Hit paper breakdown → | 2013 | 913 |
| 3 | Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy With or Without Carboplatin in Human Epidermal Growth Factor Receptor 2–Positive and Triple-Negative Primary Breast Cancers Hit paper breakdown → | 2014 | 868 |
| 4 | Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies Hit paper breakdown → | 2010 | 575 |
| 5 | 2018 | 350 | |
| 6 | 1999 | 325 | |
| 7 | 2017 | 303 | |
| 8 | 2013 | 294 | |
| 9 | 2003 | 281 | |
| 10 | A new noninvasive approach in breast cancer therapy using magnetic resonance imaging-guided focused ultrasound surgery. | 2001 | 266 |
| 11 | 2011 | 265 | |
| 12 | 2016 | 238 | |
| 13 | 2014 | 224 | |
| 14 | 2020 | 174 | |
| 15 | 2020 | 153 | |
| 16 | 2006 | 151 | |
| 17 | 2012 | 149 | |
| 18 | 2016 | 149 | |
| 19 | 2011 | 144 | |
| 20 | 2020 | 142 |
About Hans‐Peter Sinn
Hans‐Peter Sinn is a scholar working on Cancer Research, Oncology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging, having authored 333 papers that have together received 15.8k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (106 papers), Breast Lesions and Carcinomas (36 papers), Cancer Cells and Metastasis (31 papers), HER2/EGFR in Cancer Research (29 papers), Cancer Genomics and Diagnostics (26 papers), Cancer Immunotherapy and Biomarkers (18 papers), Advanced Breast Cancer Therapies (16 papers) and Cancer and Skin Lesions (15 papers). The work is most often cited by research in Cancer Research (5.0k citations), Oncology (5.9k citations), Pathology and Forensic Medicine (1.3k citations), Immunology (1.6k citations) and Radiology, Nuclear Medicine and Imaging (1.5k citations). Hans‐Peter Sinn has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Andreas Schneeweiß, Hans Heinrich Kreipe, Sebastian Aulmann, H. Junkermann, Frederik Marmé, Christof Sohn, Florian Schütz, Michael Golatta, Wilko Weichert and Peter Schirmacher. Their work appears in journals such as Breast Care, Breast Cancer Research and Treatment, International Journal of Cancer, Annals of Oncology and Modern Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.